ICOS and lung cancer: ICOS was found to be positive in 58% (n = 31 of 54) of all lung cancer samples, and ICOS was categorized as negative in 42% (n = 23 of 54), low in 17% (n = 9 of 54), and high in 41% (n = 22 of 54).